# RHA® 4 NLF Cannula

> **NCT04754646** · NA · COMPLETED · sponsor: **Teoxane SA** · enrollment: 50 (actual)

## Conditions studied

- Wrinkle
- Nasolabial Fold
- Aging

## Interventions

- **DEVICE:** Split-face injection of RHA® 4 with a cannula into a single NLF.
- **DEVICE:** Split-face injection of RHA® 4 with a needle (TSK 27G x ½") into the contralateral NLF.

## Key facts

- **NCT ID:** NCT04754646
- **Lead sponsor:** Teoxane SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-15
- **Primary completion:** 2021-08-17
- **Final completion:** 2021-11-29
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04754646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04754646, "RHA® 4 NLF Cannula". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04754646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*